BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmad S, Abbas M, Ullah MF, Aziz MH, Beylerli O, Alam MA, Syed MA, Uddin S, Ahmad A. Long non-coding RNAs regulated NF-κB signaling in cancer metastasis: Micromanaging by not so small non-coding RNAs. Semin Cancer Biol 2021:S1044-579X(21)00210-8. [PMID: 34314819 DOI: 10.1016/j.semcancer.2021.07.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Han X, Li B, Zhang S. MIR503HG: A potential diagnostic and therapeutic target in human diseases. Biomed Pharmacother 2023;160:114314. [PMID: 36736276 DOI: 10.1016/j.biopha.2023.114314] [Reference Citation Analysis]
2 Bai Z, Lu J, Chen A, Zheng X, Wu M, Tan Z, Xie J. Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning. Biomolecules 2022;12. [PMID: 36551318 DOI: 10.3390/biom12121890] [Reference Citation Analysis]
3 Sufianova G, Shumadalova A, Wenhao Y, Gareev I. Long non-coding RNAs as biomarkers and therapeutic targets for ischemic stroke. Noncoding RNA Res 2022;7:226-32. [PMID: 36187570 DOI: 10.1016/j.ncrna.2022.09.004] [Reference Citation Analysis]
4 Zhao Y, Xiang Q, Chen J, Zhang L, Zheng W, Ke D, Shi R, Yang K. SLC25A25-AS1 over-expression could be predicted the dismal prognosis and was related to the immune microenvironment in prostate cancer. Front Oncol 2022;12:990247. [DOI: 10.3389/fonc.2022.990247] [Reference Citation Analysis]
5 Liu J, Cai H, Yi H, Li X, Peng Y, Li L, Li T. Influence of Dehydroxymethylepoxyquinomicin on Radiosensitivity of Thyroid Carcinoma TPC-1 Cells. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/5026308] [Reference Citation Analysis]
6 Wu Z, Lun P, Ji T, Niu J, Sun X, Liu X, Xu J. LncRNA SNHG25 Promotes Glioma Progression Through Activating MAPK Signaling. Mol Neurobiol 2022. [PMID: 36071306 DOI: 10.1007/s12035-022-03015-x] [Reference Citation Analysis]
7 Nengroo MA, Khan MA, Verma A, Datta D. Demystifying the CXCR4 conundrum in cancer biology: Beyond the surface signaling paradigm. Biochim Biophys Acta Rev Cancer 2022;:188790. [PMID: 36058380 DOI: 10.1016/j.bbcan.2022.188790] [Reference Citation Analysis]
8 Fan N, Fu H, Feng X, Chen Y, Wang J, Wu Y, Bian Y, Li Y. Long non-coding RNAs play an important regulatory role in tumorigenesis and tumor progression through aerobic glycolysis. Front Mol Biosci 2022;9:941653. [DOI: 10.3389/fmolb.2022.941653] [Reference Citation Analysis]
9 Guo W, Liu G, Guan J, Chen Y, Zhao Y, Wang K, Bai O. Epigenetic regulation of cutaneous T-cell lymphoma is mediated by dysregulated lncRNA MALAT1 through modulation of tumor microenvironment. Front Oncol 2022;12:977266. [DOI: 10.3389/fonc.2022.977266] [Reference Citation Analysis]
10 Alsayed RKME, Khan AQ, Ahmad F, Ansari AW, Alam MA, Buddenkotte J, Steinhoff M, Uddin S, Ahmad A. Epigenetic Regulation of CXCR4 Signaling in Cancer Pathogenesis and Progression. Semin Cancer Biol 2022:S1044-579X(22)00075-X. [PMID: 35346802 DOI: 10.1016/j.semcancer.2022.03.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Arora S, Khan S, Zaki A, Tabassum G, Mohsin M, Bhutto HN, Ahmad T, Fatma T, Syed MA. Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.03.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Wang PZ, Wei W. Special issue: Targeting cellular signaling pathways for cancer therapy. Semin Cancer Biol 2021:S1044-579X(21)00225-X. [PMID: 34487833 DOI: 10.1016/j.semcancer.2021.09.001] [Reference Citation Analysis]